The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global OTC Anti-Infective Medicine Market Research Report 2024
Synopsis
Anti-infectives are medicines that work to prevent or treat infections, they include antibacterials, antivirals, antifungals and antiparasitic medications.
Global OTC Anti-Infective Medicine market is projected to reach US$ 17370 million in 2029, increasing from US$ 13730 million in 2022, with the CAGR of 3.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole OTC Anti-Infective Medicine market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global OTC Anti-Infective Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
GlaxoSmithKline
Merck
Pfizer
Novartis
Abbott
Sanofi
Bristol-Myers Squibb
Roche
Segment by Type
Antibacterials Medicine
Antivirals Medicine
Antifungals Medicine
Antiparasitic Medicine
Segment by Application
Hospital
Retail Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The OTC Anti-Infective Medicine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Anti-infectives are medicines that work to prevent or treat infections, they include antibacterials, antivirals, antifungals and antiparasitic medications.
Global OTC Anti-Infective Medicine market is projected to reach US$ 17370 million in 2029, increasing from US$ 13730 million in 2022, with the CAGR of 3.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole OTC Anti-Infective Medicine market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global OTC Anti-Infective Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
GlaxoSmithKline
Merck
Pfizer
Novartis
Abbott
Sanofi
Bristol-Myers Squibb
Roche
Segment by Type
Antibacterials Medicine
Antivirals Medicine
Antifungals Medicine
Antiparasitic Medicine
Segment by Application
Hospital
Retail Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The OTC Anti-Infective Medicine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OTC Anti-Infective Medicine Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Antibacterials Medicine
1.2.3 Antivirals Medicine
1.2.4 Antifungals Medicine
1.2.5 Antiparasitic Medicine
1.3 Market by Application
1.3.1 Global OTC Anti-Infective Medicine Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global OTC Anti-Infective Medicine Market Perspective (2018-2029)
2.2 OTC Anti-Infective Medicine Growth Trends by Region
2.2.1 Global OTC Anti-Infective Medicine Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 OTC Anti-Infective Medicine Historic Market Size by Region (2018-2023)
2.2.3 OTC Anti-Infective Medicine Forecasted Market Size by Region (2024-2029)
2.3 OTC Anti-Infective Medicine Market Dynamics
2.3.1 OTC Anti-Infective Medicine Industry Trends
2.3.2 OTC Anti-Infective Medicine Market Drivers
2.3.3 OTC Anti-Infective Medicine Market Challenges
2.3.4 OTC Anti-Infective Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top OTC Anti-Infective Medicine Players by Revenue
3.1.1 Global Top OTC Anti-Infective Medicine Players by Revenue (2018-2023)
3.1.2 Global OTC Anti-Infective Medicine Revenue Market Share by Players (2018-2023)
3.2 Global OTC Anti-Infective Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by OTC Anti-Infective Medicine Revenue
3.4 Global OTC Anti-Infective Medicine Market Concentration Ratio
3.4.1 Global OTC Anti-Infective Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OTC Anti-Infective Medicine Revenue in 2022
3.5 OTC Anti-Infective Medicine Key Players Head office and Area Served
3.6 Key Players OTC Anti-Infective Medicine Product Solution and Service
3.7 Date of Enter into OTC Anti-Infective Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 OTC Anti-Infective Medicine Breakdown Data by Type
4.1 Global OTC Anti-Infective Medicine Historic Market Size by Type (2018-2023)
4.2 Global OTC Anti-Infective Medicine Forecasted Market Size by Type (2024-2029)
5 OTC Anti-Infective Medicine Breakdown Data by Application
5.1 Global OTC Anti-Infective Medicine Historic Market Size by Application (2018-2023)
5.2 Global OTC Anti-Infective Medicine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America OTC Anti-Infective Medicine Market Size (2018-2029)
6.2 North America OTC Anti-Infective Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America OTC Anti-Infective Medicine Market Size by Country (2018-2023)
6.4 North America OTC Anti-Infective Medicine Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe OTC Anti-Infective Medicine Market Size (2018-2029)
7.2 Europe OTC Anti-Infective Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe OTC Anti-Infective Medicine Market Size by Country (2018-2023)
7.4 Europe OTC Anti-Infective Medicine Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific OTC Anti-Infective Medicine Market Size (2018-2029)
8.2 Asia-Pacific OTC Anti-Infective Medicine Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific OTC Anti-Infective Medicine Market Size by Region (2018-2023)
8.4 Asia-Pacific OTC Anti-Infective Medicine Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America OTC Anti-Infective Medicine Market Size (2018-2029)
9.2 Latin America OTC Anti-Infective Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America OTC Anti-Infective Medicine Market Size by Country (2018-2023)
9.4 Latin America OTC Anti-Infective Medicine Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa OTC Anti-Infective Medicine Market Size (2018-2029)
10.2 Middle East & Africa OTC Anti-Infective Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa OTC Anti-Infective Medicine Market Size by Country (2018-2023)
10.4 Middle East & Africa OTC Anti-Infective Medicine Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Detail
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline OTC Anti-Infective Medicine Introduction
11.1.4 GlaxoSmithKline Revenue in OTC Anti-Infective Medicine Business (2018-2023)
11.1.5 GlaxoSmithKline Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck OTC Anti-Infective Medicine Introduction
11.2.4 Merck Revenue in OTC Anti-Infective Medicine Business (2018-2023)
11.2.5 Merck Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer OTC Anti-Infective Medicine Introduction
11.3.4 Pfizer Revenue in OTC Anti-Infective Medicine Business (2018-2023)
11.3.5 Pfizer Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis OTC Anti-Infective Medicine Introduction
11.4.4 Novartis Revenue in OTC Anti-Infective Medicine Business (2018-2023)
11.4.5 Novartis Recent Development
11.5 Abbott
11.5.1 Abbott Company Detail
11.5.2 Abbott Business Overview
11.5.3 Abbott OTC Anti-Infective Medicine Introduction
11.5.4 Abbott Revenue in OTC Anti-Infective Medicine Business (2018-2023)
11.5.5 Abbott Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Detail
11.6.2 Sanofi Business Overview
11.6.3 Sanofi OTC Anti-Infective Medicine Introduction
11.6.4 Sanofi Revenue in OTC Anti-Infective Medicine Business (2018-2023)
11.6.5 Sanofi Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Detail
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb OTC Anti-Infective Medicine Introduction
11.7.4 Bristol-Myers Squibb Revenue in OTC Anti-Infective Medicine Business (2018-2023)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Roche
11.8.1 Roche Company Detail
11.8.2 Roche Business Overview
11.8.3 Roche OTC Anti-Infective Medicine Introduction
11.8.4 Roche Revenue in OTC Anti-Infective Medicine Business (2018-2023)
11.8.5 Roche Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
